R T D Oliver
Overview
Explore the profile of R T D Oliver including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
233
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Shaw G, Oliver R
Surg Oncol
. 2009 Mar;
18(3):275-82.
PMID: 19269165
Castration results in dangerous and disabling side effects. Deferred hormone therapy has been shown to be associated with decreased survival. Intermittent hormone therapy (IHT) was attempted initially to reduce morbidity...
3.
Murugaesu N, Powles T, Bestwick J, Oliver R, Shamash J
Osteoporos Int
. 2008 Nov;
20(9):1627-30.
PMID: 19030945
Unlabelled: Most patients with testis cancer are cured with treatment. However, the incidence of osteoporosis after prolonged follow-up is unknown. This study investigates the incidence of osteoporosis in 39 testis...
4.
Berney D, Fisher G, Kattan M, Oliver R, Moller H, Fearn P, et al.
Histopathology
. 2007 Sep;
51(4):452-7.
PMID: 17880526
Aims: To assess the possible reasons for error in the diagnosis of prostatic cancer with available follow-up data. Method And Results: A cohort of 1791 cases of prostatic cancer diagnosed...
5.
Shamash J, Powles T, Ansell W, Berney D, Stebbing J, Mutsvangwa K, et al.
Br J Cancer
. 2007 Jul;
97(3):308-14.
PMID: 17609665
There is no consensus as to the management of untreated poor prognosis or relapsed/refractory germ cell tumours. We have studied an intensive cisplatin-based regimen that incorporates high-dose methotrexate (HD MTX)...
6.
Strefford J, Lane T, Hill A, Leroux L, Foot N, Shipley J, et al.
Cytogenet Genome Res
. 2005 Nov;
112(1-2):45-52.
PMID: 16276089
Although chromosome translocations are well-documented recurrent events in hematological malignancies and soft tissue sarcomas, their significance in carcinomas is less clear. We report here the molecular characterization of the reciprocal...
7.
Oliver R, Mason M, Mead G, von der Maase H, Rustin G, Joffe J, et al.
Lancet
. 2005 Jul;
366(9482):293-300.
PMID: 16039331
Background: Adjuvant radiotherapy is effective treatment for stage I seminoma, but is associated with a risk of late non-germ-cell cancer and cardiovascular events. After good results in initial studies with...
8.
Youshya S, Purdie K, Breuer J, Proby C, Sheaf M, Oliver R, et al.
J Clin Pathol
. 2005 Jan;
58(2):207-10.
PMID: 15677544
Aim: To investigate the role of human papillomavirus (HPV) in the development of bladder transitional cell carcinoma (TCC). Methods: Seventy eight paraffin wax embedded TCC samples were tested for the...
9.
Shamash J, Dancey G, Barlow C, Wilson P, Ansell W, Oliver R
Br J Cancer
. 2004 Dec;
92(1):36-40.
PMID: 15570307
The management of androgen independent prostate cancer is increasingly disputed. Diethylstilbestrol and steroids have useful second-line activity in its management. The value of chemotherapy still remains contentious. This paper reports...
10.
Lane T, Ansell W, Farrugia D, Wilson P, Williams G, Chinegwundoh F, et al.
Urol Int
. 2004 Aug;
73(2):117-22.
PMID: 15331894
Objectives: To assess the long-term outcomes of patients with prostate cancer managed with intermittent androgen suppression (IAS) following their enrollment in an open, non-randomised feasibility study initiated 10 years ago....